Biotechnology

Antiverse

Antiverse is an AI-native company in Biotechnology, based in United Kingdom. Shown below: 1 funding round.

AI-native Not profitable Featured: — GB

$56M

Listed valuation

Visit website
Raised
$9.30M
Rounds
1

Figures and classifications reflect imported catalog records, not live company reporting.

Funding rounds

1 round

  • Series A Announced 03 Mar 2026
    $9.30M Raised $9.30M Round 3 investors Announced

Source rankings

Imported positions; not an independent quality score.

  • Overall Rank#1957
  • AI Native Rank#972
  • Rank#89